Sequence Biotech Private Limited - Charges

Every charge - open or closed - that lenders have registered against Sequence Biotech Private Limited, with the most recent activity at the …

2008-09-19 Nashik, Maharashtra Active Unlisted Active Compliant
Share
View plans
SB Sequence Biotech Private Limited
Open charges
3
6.02 cr
Closed charges
0
0.00
Total
3
6.02 cr
Open vs closed
Top charge holders (by amount)
Top lenders
#LenderChargesAmount
1 Bank Of Maharashtra 1 5.40 cr
2 Others 2 61.84 Lakh
All charges (3) - latest first
Charge ID Charge holder Created Modified Satisfied Amount Status
101006403 Others 21 Nov 2024 - - 20.35 Lakh Open
101007565 Others 27 Sep 2024 30 Sep 2024 - 41.49 Lakh Open
10298913 Bank Of Maharashtra 09 Jun 2011 29 Nov 2012 - 5.40 cr Open
Frequently Asked Questions - Charges & borrowings
What do "charges" mean for Sequence Biotech Private Limited?
Charges are registrable security interests-typically loans or credit facilities-filed with MCA against Sequence Biotech Private Limited (CIN: U74999MH2008PTC186895). They indicate assets or undertakings pledged to lenders or charge holders.
What is the difference between open and closed charges?
Open charges are active or not yet fully discharged; closed (or satisfied) charges are recorded as settled or released. Counts and amounts on this page follow the statuses shown in the charge list.
How should I read the open vs closed amounts?
Open and closed amounts summarise registrable amounts by status for quick comparison; individual rows may show charge-specific amounts, holders, and dates for verification.
Who are the "top lenders" or charge holders?
Top lenders group charge holders by bank or institution name and approximate exposure so you can see which lenders appear most prominently for Sequence Biotech Private Limited.
Where can I cross-check financial or ownership context?
Pair this Charges view with the Financial and Ownership sections on this company's V1 profile for loans in financial statements and cap table context alongside MCA charge filings.